Home / Europe / Portugal / Life Sciences & Healthcare

Life Sciences & Healthcare

In a ever-changing world, with new regulatory requirements, in which technology plays an increasingly important role in the development of global strategies, the area of health, medical devices, pharmaceuticals and new branches of sciences such as biotechnology raise several legal issues and present high complexity and specificity.

The transition to a remote and essentially digital working environment has not been particularly difficult, however, the diversity of entities involved, the existing regulation and the operation of the market itself raise several legal issues and present high complexity and specificity.

Whatever your opportunities or challenges may be, our dedicated team understands your needs and works to strategically define tailor-made solutions.

We can help you shape your strategy, manage risks and make the most of business opportunities in these areas:

  • Regulation
  • Licensing
  • Financing, mergers and acquisitions
  • Business restructuring
  • Litigation
  • Clinical Research
  • Distribution
  • Patents Protection and enforcement
  • Labelling
  • Safety and Health
  • Competition
  • Public Offers
  • Environment

We have an in-depth knowledge of how life sciences and healthcare law applies in practice across different markets and with cross-disciplinary teams, we work to provide advice close to our clients’ needs.


Feed

29/04/2024
On your radar | Key employment issues to be aware of internationally
We are delighted to share with you our latest and largest edition of On Your Radar, with contributions from 35 countries.   As ever, you will find employment law updates covering a diverse range of topical...
25/04/2024
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? For all matters not foreseen in the Legal Regime of Human Medicinal Products or the Regulation on Medical Devices and...
11/04/2024
Navigating clinical trial disclosures: No reasonable expectation of success...
Recent EPO Board of Appeal decision T 1437/21 adds to a growing number of decisions concerning the patentability of second or further medical use inventions where the prior art relates to a clinical trial...
27/03/2024
Cannabis law and legislation in Portugal
Medical use Under the Portuguese Law, the use of cannabis for medical purposes is admissible, provided the necessary requirements and the mandatory licenses are obtained. The Portuguese legal framework...
25/03/2024
Patentability of inventions relating to diagnostic methods at the EPO
Under Article 53(c) of the European Patent Convention (EPC), diagnostic methods practised on the human or animal body are excluded from patentability. The purpose behind this exclusion is to avoid patent...
30/01/2024
What’s in a name? Updated EMA guideline on naming medicinal products processed...
The updated EMA Guideline on the acceptability of names for human medicinal products processed through the centralised procedure was adopted by CHMP in December 2023 and came into effect on 1 January...
08/01/2024
Adapting to the new EU Data Act: implications for medical devices and other...
In recent years, the European Commission developed a European data strategy, which aims to create a single European market in which data can circulate freely. As the European Commission has emphasized...
08/12/2023
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
08/11/2023
CMS Life Sciences Vital Signs, Winter 2023
2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed...
28/09/2023
EP Case Law in Brief: Erroneous Disclosures
“Mistakes in a document do not in themselves constitute prior art such as to prevent the grant of a patent.”So begins section I.C. 4.9 of the Case Law of the Boards of Appeal. This statement, and...
15/08/2023
AI in healthcare inventions – technical or not technical?
SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare...
28/06/2023
UK announces £21m AI roll-out across NHS
IntroductionOn 23 June 2023, the UK government announced a £21 million fund aimed at accelerating the deployment of Artificial Intelligence (“AI”) across the National Health Service (“NHS”)...